Identification of Baseline Clinical Factors Which Predict Medical Treatment Failure of Benign Prostatic Hyperplasia: An Observational Cohort Study

By Hong S.J.   Ko W.J.   Kim S.I.   Chung B.H.  

European Urology, Vol. 44, Iss. 1, 2003-07 ,pp. : 94-100

Elsevier

Access to resources Recommend Favorite

Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia

By Putzi M.J.   De Marzo A.M.  

Urology, Vol. 56, Iss. 5, 2000-11 ,pp. : 828-832

Elsevier

Access to resources Recommend Favorite

Testicular Effects of Vasectomy in Rats: An Ultrastructural and Immunohistochemical Study - Immunohistochemical and serological evidence

By Aydos K.   Soygur T.   Kupeli B.   Unsal A.   Tolunay O.   Erdem E.   Guven C.   Kupeli S.  

Urology, Vol. 51, Iss. 6, 1998-06 ,pp. : 1051-1056

Elsevier

Access to resources Recommend Favorite

Long-term treatment and prognostic factors of α₁-blockers for lower urinary tract symptoms associated with benign prostatic hyperplasia: A pilot study comparing naftopidil and tamsulosin hydrochloride

By Kawachi Yoshio   Sakurai Toru   Sugimura Sosuke   Iwata Shinji   Noto Kensho   Honda Shin-Ichi   Maruyama Osamu  

Scandinavian Journal of Urology and Nephrology, Vol. 44, Iss. 1, 2010-02 ,pp. : 38-45

Informa Healthcare

Access to resources Recommend Favorite

Urogenital Prolapse and Atrophy at Menopause: A Prevalence Study

By Versi E.   Harvey M.-A.   Cardozo L.   Brincat M.   Studd J. W. W.  

International Urogynecology Journal, Vol. 12, Iss. 2, 2001-04 ,pp. : 107-110

Springer Publishing Company

Access to resources Recommend Favorite